Global Migraine Drugs Market Analysis 2019

Global Migraine Drugs Market Analysis 2019

The Global Migraine Drugs market is expected to reach $6.94 billion by 2026 growing at a CAGR of 17.2% from 2018 to 2026. Migraine is a clinical condition related with painful headaches and other different symptoms for example, nausea, sensitivity to smell, and others. These headaches generally occur on one side of the head and each and every episode of migraine has different duration and intensity. Migraine drugs are utilized in the treatment of headaches related with migraine. Factors for example, rise in female population and surge in awareness among patients related to prevention and treatment are driving the market growth. Though, side effects associated with these drugs are projected to inhibit the growth of the market.

By drug type, abortive medicines segment acquired significant growth in the market as they can be taken by self-injection, mouth, skin patch, or nasal spray. These forms of medication are especially useful for people who have nausea or vomiting related to their migraine, and they work quickly.

The key vendors mentioned are Abbott, Allergan, AstraZeneca, Bayer, Eli Lilly, Endo International, Ethypharm, GlaxoSmithKline, Impax, Johnson and Johnson, Kowa Pharmaceuticals America, Merck, Pfizer, Teva and Winston Pharmaceuticals.

Types Covered:
• Abortive Medicines
• Preventive medicines
• Rizatriptan
• Sumatriptan
• Zolmitriptan
• Ergot Alkaloids
• Other Drug Types

Drug Classes Covered:
• Calcitonin Gene-Related Peptide (CGRP)
• Acetylcholine Inhibitors/ Neurotoxins

Products Covered:
• Therapeutic Class
• Treatment Class

Route of Administrations Covered:
• Injection
• Oral
• Other Route of Administrations

Applications Covered:
• Clinics
• Hospitals
• Household Use
• Other Applications

End Users Covered:
• Retail Pharmacies
• Online Pharmacies
• Hospitals Based Pharmacies

Regions Covered:
• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Key Questions Answered in this Report:
• How this market evolved since the year 2016
• Market size estimations, forecasts and CAGR for all the segments presented in the scope
• Key Market Developments and financials of the key players
• Opportunity Analysis for the new entrants
• SWOT Analysis of the key players
• Fastest growing markets analysed during the forecast period